Skin News and Research

RSS

Vegan honey could match powerful antimicrobial properties of mānuka

Vegan honey alternatives could be engineered to have similar antimicrobial properties to prized mānuka honey from New Zealand, according to research at Aston University.

15 Oct 2026

New study reveals how Candida auris evades antifungal drugs

New research has revealed an unexpected new mechanism through which the killer fungus Candida auris is resisting antifungal drug treatment.

15 Oct 2026

New imaging technique detects subtle skin changes in scleroderma patients

Scleroderma (systemic sclerosis) is a rare, chronic, autoimmune disease that causes the body to produce too much collagen, leading to the hardening and thickening of the skin and internal organs.

14 Oct 2026

Does the type of hand sanitizer matter? A study involving 568 people suggests it might

In a 72-day randomized trial involving 568 participants in Japan, an experimental hand sanitizer containing ethanol, benzalkonium chloride, and lactic acid was associated with a 40% lower cumulative incidence of upper respiratory symptoms than a commercial ethanol-based sanitizer. Participants using the experimental formulation also experienced fewer illness-related work restrictions, although infections were not laboratory-confirmed and the proposed residual antimicrobial mechanism was not directly tested.

14 Oct 2026

Skin conductance measurements reveal link between insomnia and disrupted fear regulation

A new computational model using skin conductance measurements to estimate stress-related emotional arousal found a significant difference in learned fear and safety responses over time between adults with and without insomnia.

14 Oct 2026

Sex hormones dictate how skin stem cells renew themselves

For a long time, differences between females and males were mainly associated with the reproductive organs. Yet organs that have nothing to do with reproduction, such as the skin, can also be shaped by sex.

14 Oct 2026

Understanding how neutrophil signaling pathways disrupt the human intestinal barrier

The intestinal mucosal barrier separates the host from the gut lumen and is essential for systemic homeostasis.

14 Oct 2026

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026

Common blood pressure drug boosts brown adipose tissue activity and metabolism

Scientists have discovered that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism.

14 Oct 2026

Mosquito saliva study opens new doors for blocking Zika, Dengue, and West Nile infections

Mosquitoes do more than simply transmit the viruses they carry: their saliva may actively help these viruses establish infection in the body from the very moment of the bite.

14 Oct 2026

Topical peptide spray outperforms placebo in healing burn wounds

Burn wound infections remain a major global health burden, often requiring hospitalization and delaying tissue repair.

13 Oct 2026

Developing biomaterials for soft tissue reconstruction

Explore how biomaterials and additive manufacturing support medical device development for soft tissue reconstruction.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 13 Oct 2026

Targeting the RUNX1 gene helps reduce severe skin fibrosis

Skin fibrosis includes hypertrophic scar (HTS), keloid scar (KS), and systemic sclerosis (SSc). These conditions share persistent fibroblast activation, excessive extracellular matrix (ECM) deposition, and progressive skin remodeling.

13 Oct 2026

Review highlights EP4 receptor as target for inflammatory diseases

A review published in Genes & Diseases highlights the prostaglandin E2 receptor subtype 4 (EP4) as an important regulator of inflammation and a promising therapeutic target for a wide range of inflammatory and inflammation-related diseases.

12 Oct 2026

Researchers followed glucose monitor users for three years and found a possible kidney benefit

A study of more than 25,000 analytical group assignments involving high-risk adults with type 2 diabetes found that sustained real-time continuous glucose monitoring (rtCGM) was associated with substantial improvements in blood sugar control over three years. Continued use was also linked to lower levels of a marker of kidney damage after three years, although researchers found no evidence that the technology preserved kidney filtration function.

12 Oct 2026